This article details Sid Sijbrandij's battle with cancer after his diagnosis in 2022. Using a systematic approach similar to his work with GitLab, he created an extensive documentation process and personalized treatment plan, ultimately leading to his remission. It explores broader implications for cancer care and drug development.